High-Quality HER-2 Testing
作者： Elizabeth L. Wiley , Leslie K. Diaz
关键词:
摘要:
sci-hub.se 参考文章(14)
Godolphin W, Pauletti G, Press Mf, Slamon Dj, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. ,vol. 13, pp. 63- 72 ,(1996)
Lauren Hammock, Melinda Lewis, Carol Phillips, Cynthia Cohen, Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization1 1This manuscript consists of original material not previously accepted for publication by another journal. The manuscript does not include use of any investigational or “off-label” products. The authors do not have a financial or other relationship with any of the commercial enterprises whose products or services may be discussed in this original article. Human Pathology. ,vol. 34, pp. 1043- 1047 ,(2003) , 10.1053/S0046-8177(03)00409-X
Edith A. Perez, Patrick C. Roche, Robert B. Jenkins, Carol A. Reynolds, Kevin C. Halling, James N. Ingle, Lester E. Wold, HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization Mayo Clinic Proceedings. ,vol. 77, pp. 148- 154 ,(2002) , 10.4065/77.2.148
Hadi Yaziji, HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods JAMA. ,vol. 291, pp. 1972- 1977 ,(2004) , 10.1001/JAMA.291.16.1972
Ren L Ridolfi, Mehdi R Jamehdor, Janet M Arber, HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Modern Pathology. ,vol. 13, pp. 866- 873 ,(2000) , 10.1038/MODPATHOL.3880154
D. Slamon, W Godolphin, L. Jones, J. Holt, S. Wong, D. Keith, W. Levin, S. Stuart, J Udove, A Ullrich, al. et, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. ,vol. 244, pp. 707- 712 ,(1989) , 10.1126/SCIENCE.2470152
Mai P. Hoang, Aysegul A. Sahin, Nelson G. Ordòñez, Nour Sneige, HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. American Journal of Clinical Pathology. ,vol. 113, pp. 852- 859 ,(2000) , 10.1309/VACP-VLQA-G9DX-VUDF
Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji, Melissa J. Barnes, Stuart J. Schnitt, Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System Journal of Clinical Oncology. ,vol. 17, pp. 1983- 1983 ,(1999) , 10.1200/JCO.1999.17.7.1983
P. C. Roche, V. J. Suman, R. B. Jenkins, N. E. Davidson, S. Martino, P. A. Kaufman, F. K. Addo, B. Murphy, J. N. Ingle, E. A. Perez, Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831 Journal of the National Cancer Institute. ,vol. 94, pp. 855- 857 ,(2002) , 10.1093/JNCI/94.11.855
Jeffrey S. Ross, Jonathan A. Fletcher, Gerald P. Linette, James Stec, Edward Clark, Mark Ayers, W. Fraser Symmans, Lajos Pusztai, Kenneth J. Bloom, The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy Oncologist. ,vol. 8, pp. 307- 325 ,(2003) , 10.1634/THEONCOLOGIST.8-4-307